tradingkey.logo

Zyversa Therapeutics Inc

ZVSA
0.311USD
0.000
Close 12/19, 16:00ETQuotes delayed by 15 min
799.48KMarket Cap
LossP/E TTM

Zyversa Therapeutics Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-8.48
99.22%
Analyst Rating
2025-03-13

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

FAQs

What is the total revenue of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.

What is the Earnings Per Share (EPS) of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -8.480, with a year-on-year change of 99.22%.

What is the net income of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its net income was -9.41M, with a year-on-year change of 91.14%.

What is the net margin of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.

What is the gross margin of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.

What is the debt-to-asset ratio of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.

What is the Return on Equity (ROE) of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -96.10%, with a year-on-year change of 49.77%.

What is the Return on Assets (ROA) of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -44.08%, with a year-on-year change of 68.47%.

What is the operating profit of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its operating profit was -9.14M, with a year-on-year change of 36.64%.

What are the current assets of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its current assets were 1.72M, with a year-on-year change of -48.83%.

What are the total assets of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its total assets of Zyversa Therapeutics Inc were 20.60M, with a year-on-year change of -6.85%.

What are the total liabilities of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its total liabilities of Zyversa Therapeutics Inc were 12.08M, with a year-on-year change of 9.45%.

What is the total equity of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its total equity of Zyversa Therapeutics Inc was 8.52M, with a year-on-year change of -23.10%.

What is the net operating income of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its net operating income of Zyversa Therapeutics Inc was -9.41M, with a year-on-year change of 90.42%.

What is the net investment of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its net investment of Zyversa Therapeutics Inc was --, with a year-on-year change of --.

What is the net financing of Zyversa Therapeutics Inc?

According to Zyversa Therapeutics Inc's FY2024 earnings report, its net financing of Zyversa Therapeutics Inc was 5.95M, with a year-on-year change of -0.06%.
KeyAI